Cefoxitin

Cefoxitin Struktur
35607-66-0
CAS-Nr.
35607-66-0
Bezeichnung:
Cefoxitin
Englisch Name:
Cefoxitin
Synonyma:
cfx;C06887;Mefoxin;CEFOXITIN;Rephoxitin;cephoxitin;Cefoxitinum;CEFOXITIN ACID;Cefoxitin (500 mg);Cefoxitin(Mefoxin)
CBNumber:
CB9490581
Summenformel:
C16H17N3O7S2
Molgewicht:
427.45
MOL-Datei:
35607-66-0.mol

Cefoxitin Eigenschaften

Schmelzpunkt:
149-150℃
Siedepunkt:
843℃
Dichte
1.4441 (rough estimate)
Brechungsindex
1.6390 (estimate)
RTECS-Nr.
XI0386500
Flammpunkt:
>110°(230°F)
storage temp. 
2-8°C
Löslichkeit
DMSO (Slightly), Methanol (Slightly)
Aggregatzustand
Solid
pka
2.2(at 25℃)
Farbe
White to Off-White
Wasserlöslichkeit
Predicted solubility in water is less than 0.2mg/ml
CAS Datenbank
35607-66-0(CAS DataBase Reference)
EPA chemische Informationen
Cefoxitin (35607-66-0)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
RIDADR  3077
HazardClass  9
PackingGroup  III
HS Code  30032013
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H317 Kann allergische Hautreaktionen verursachen. Sensibilisierung der Haut Kategorie 1A Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P261, P272, P280, P302+P352,P333+P313, P321, P363, P501
Sicherheit
P261 Einatmen von Staub vermeiden.
P321 Besondere Behandlung
P333+P313 Bei Hautreizung oder -ausschlag: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

Cefoxitin Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Cefoxitin contains the same C-7 side chain as cephalothin and the same C-3 side chain as cefuroxime. The most novel chemical feature of cefoxitin is the possession of an α-oriented methoxyl group in place of the normal H-atom at C-7. This increased steric bulk conveys very significant stability against β-lactamases. The inspiration for these functional groups was provided by the discovery of the naturally occurring antibiotic cephamycin C derived from fermentation of Streptomyces lactamdurans. Cephamycin C itself has not seen clinical use but, rather, has provided the structural clue that led to useful agents such as cefoxitin. Agents that contain this 7α methoxy group are commonly referred to as cephamycins. Ingenious chemical transformations now enable synthetic introduction of such a methoxy group into cephalosporins lacking this feature.

Verwenden

Cefoxitin?is a semisynthetic, broad-spectrum second-generation cephalosporin with antibacterial activity. The activity of cefoxitin results in the weakening of the bacterial cell wall and causes cell lysis. Cefoxitin acts by interfering with cell wall synthesis. Its activity spectrum includes a broad range of gram-negative and gram-positive bacteria including anaerobes.

Antimicrobial activity

Most Gram-positive bacilli are susceptible, but L. monocytogenes is resistant. It is resistant to many Gramnegative β-lactamases and is active against organisms elaborating them, including some Citrobacter, Providencia, Serratia and Acinetobacter spp. Enterobacter spp. are resistant. It is moderately active against Bacteroides spp., but considerable strain variation in susceptibility occurs.

Acquired resistance

Resistant strains of Bacteroides, some of which produce β-lactamases that hydrolyze cefoxitin, have been described. Resistance may be transferable to other Bacteroides spp. It is a potent inducer of chromosomal cephalosporinases of certain Gram-negative bacilli and can antagonize the effect of cefotaxime and other β-lactam agents.

Clinical Use

As for other group 3 cephalosporins, with particular emphasis on mixed infections including anaerobes, notably abdominal and pelvic sepsis. In considering its use, its low activity against aerobic Gram-positive cocci should be noted.

Nebenwirkungen

Reactions are those common to cephalosporins. Pain on intramuscular, and thrombophlebitis on intravenous, injection occur. Substantial changes can occur in the fecal flora, with virtual eradication of susceptible enterobacteria and non- fragilis Bacteroides, and appearance of, or increase in, yeasts, enterococci and other resistant bacteria including C. difficile. Development of meningitis due to H. influenzae and Str. pneumoniae in patients treated for other infections has been observed.

Cefoxitin Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Cefoxitin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 233)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21695 55
Nanjing Finetech Chemical Co., Ltd.
025-85710122 17714198479
sales@fine-chemtech.com CHINA 885 55
Hubei xin bonus chemical co. LTD
86-13657291602
linda@hubeijusheng.com CHINA 22968 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427
sales@conier.com China 47465 58
career henan chemical co
+86-0371-86658258 15093356674;
factory@coreychem.com China 29826 58
Neostar United (Changzhou) Industrial Co., Ltd.
+86-519-519-85557386
marketing1@neostarunited.com China 8349 58
SIMAGCHEM CORP
+86-13806087780
sale@simagchem.com China 17367 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Hefei TNJ Chemical Industry Co.,Ltd.
0551-65418671
sales@tnjchem.com China 34572 58
Hebei Henghe Import and Export Trading Co. LTD
+8618032935937 18032916000
demi@hbtycoon.com CHINA 449 58

35607-66-0(Cefoxitin)Verwandte Suche:


  • (6r-cis)-ethyl)-7-methoxy-8-oxo-7-((2-thienylacetyl)amino)
  • cephoxitin
  • cfx
  • CEFOXITIN
  • Mefoxin
  • CEFOXITIN ACID
  • 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-, (6R,7S)-
  • 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-, (6R-cis)-
  • (6R-cis)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-(2-thienylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-, (6R,7S)-
  • Rephoxitin
  • (6R,7S)-3-(Carbamoyloxymethyl)-7β-methoxy-8-oxo-7-[(2-thienyl)acetylamino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • C06887
  • Cefoxitin (500 mg)
  • Bisoprolol FuMarate IMpurity-J
  • (6R,7S)-3-[(carbaMoyloxy)Methyl]-7-Methoxy-8-oxo-7-[2-(thiophen-2-yl)acetaMido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • Cefoxitin Solution, 100ppm
  • Cefoxitin(Mefoxin)
  • Cefoxitin【(6R-cis)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-(2-thienylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid】
  • (6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • Cefoxitin Cefoxitin
  • Cefoxitin USP/EP/BP
  • Cefoxitin (1098107)
  • Cefoxitinum
  • 35607-66-0
  • C16H17N3O7S2
  • Pharmaceutical intermediate
  • Pharmaceutical raw material
Copyright 2019 © ChemicalBook. All rights reserved